altretamine has been researched along with misonidazole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ozols, RF; Poirier, MC; Reed, E; Tarone, R; Yuspa, SH | 1 |
Lichter, AS; Myers, CC; Ostechega, Y; Ozols, RF; Young, RC | 1 |
2 other study(ies) available for altretamine and misonidazole
Article | Year |
---|---|
Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; DNA Damage; DNA, Neoplasm; Drug Evaluation; Female; Humans; Middle Aged; Misonidazole; Organoplatinum Compounds; Ovarian Neoplasms | 1987 |
The treatment of advanced stage ovarian carcinoma with a combination of chemotherapy, radiotherapy, and radiosensitizer: report of a pilot study from the National Cancer Institute.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Middle Aged; Misonidazole; Ovarian Neoplasms; Pilot Projects; Prognosis; Radiation-Sensitizing Agents | 1987 |